Market cap
$156.741 B
$27.50 +0.33%
Close of 7 Oct 2026
As of 7 Oct 2026, Pfizer (PFE) has a market capitalization of $156.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$62.6B
#66 by revenue
Earnings
$7.77B
#60 by earnings
Shares outstanding
5,699,673,589
Latest filing cover page
P/E ratio
20.2
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 499 →- #7Abbott LaboratoriesABT$169.9B
- #8Novo Nordisk A SNVO$166.2B
- #9PfizerPFE$156.7B
- #10Vertex PharmaceuticalsVRTX$127.3B
- #11Bristol Myers SquibbBMY$121.7B
What if Pfizer were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Pfizer are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.